Intriguingly, a single case report described a multiple primary lung cancer in which the adenocarcinoma of the left lobe was an EGFR mutant at exon 21 and KRAS/PTEN negative and thus, was treated with gefitinib. This evidence concerns the gene PTEN and lung cancer.